Topics to be discussed:

Time: 9:15 am
day: Day One


• Understanding the continuum of care for preventing, slowing, or reversing dry AMD at various stages of
the disease – where do pharmacological, cell therapies, gene therapy approaches, light therapies and
vision prosthesis play a role in the patient’s therapeutic journey?
• Discussing the potential for sequential or combination regimens depending on stage of disease
• Providing a potential therapeutic journey framework for dry AMD patient populations from early stages,
through to advanced cases with GA secondary to dry AMD or wet AMD